cognitive changes in Parkinson's Disease and related movement disorders, behaviours, biomarkers, neuroimaging interventions, the overlap between cognition and mobility in aging and age-related neurodegenerative disease, MRI, gait, cohort studies, mild cognitive impairment, dementia, Parkinson's disease, parkinsonism, vascular risk factors
Development of biomarker (clinical, genetic, imaging, -omic) predictors of cognitive decline in aging and degenerative disorders.
Roles and Connections
Most Cited Publications
|Montero-Odasso MM, Sarquis-Adamson Y, Speechley M, Borrie MJ, Hachinski VC, Wells J, Riccio PM, Schapira M, Sejdic E, Camicioli RM, Bartha R, McIlroy WE, Muir-Hunter S, "Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study." JAMA neurology 74,7 (2017 Jul 1): 857-865|
|Narvacan K, Treit S, Camicioli R, Martin W, Beaulieu C, "Evolution of deep gray matter volume across the human lifespan." Human brain mapping 38,8 (2017 Aug): 3771-3790|
|Montero-Odasso M, Almeida QJ, Bherer L, Burhan AM, Camicioli R, Doyon J, Fraser S, Muir-Hunter S, Li KZH, Liu-Ambrose T, McIlroy W, Middleton L, Morais JA, Sakurai R, Speechley M, Vasudev A, Beauchet O, Hausdorff JM, Rosano C, Studenski S, Verghese J, Canadian Gait and Cognition Network., "Consensus on Shared Measures of Mobility and Cognition: From the Canadian Consortium on Neurodegeneration in Aging (CCNA)." The journals of gerontology. Series A, Biological sciences and medical sciences 74,6 (2019 May 16): 897-909|